![Richard Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Williams
Chief Tech/Sci/R&D Officer at
CannBioRex Pharmaceuticals Corp.
Profile
Richard Williams currently works as a Professor at the Kennedy Institute of Rheumatology.
He is currently the Chief Scientific Officer at CannBioRex Pharmaceuticals Corp.
Richard Williams active positions
| Companies | Position | Start |
|---|---|---|
CannBioRex Pharmaceuticals Corp.
 CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel synthetic pharmaceutical products | Chief Tech/Sci/R&D Officer | 2018-04-30 |
Kennedy Institute of Rheumatology
 Kennedy Institute of Rheumatology Pharmaceuticals: MajorHealth Technology Operates translational inflammatory sciences centre, which focuses on understanding the causes of chronic inflammatory conditions to develops new treatments | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Kennedy Institute of Rheumatology
Kennedy Institute of Rheumatology Pharmaceuticals: MajorHealth Technology Operates translational inflammatory sciences centre, which focuses on understanding the causes of chronic inflammatory conditions to develops new treatments | Health Technology |
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel synthetic pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Richard Williams
